IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign

Summary

IGC Pharma is evaluating recovery options following a federal jury verdict that has renewed attention to a 2018 short campaign against the company. The article lacks specific details about the verdict outcome or potential recovery amount.